Diabetes Risk Screening Tools for Prediabetes: A Comprehensive Scoping Review of Evidence and Implementation
Open Access
- 9 October 2025
- journal article
- review article
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 28 (4) , 348-358
Abstract
BACKGROUND/OBJECTIVES: Diabetes risk screening tools are essential for identifying individuals with prediabetes and preventing the progression to diabetes. However, systematic reviews focusing on such tools, particularly for prediabetes screening, are scarce. This scoping review examines the characteristics, development methods, and effectiveness of diabetes risk assessment tools in identifying prediabetes and predicting its progression to diabetes. MATERIALS AND METHODS : A scoping review was conducted following the Joanna Briggs Institute methodology. Searches were performed in PubMed, ScienceDirect, and Google Scholar, complemented by citation tracking. Eligible studies included asymptomatic adults with prediabetes. Studies were excluded if they lacked relevant data, were not in English, or had no validation measures. Data were extracted independently by two reviewers and synthesized narratively, focusing on study design, risk model features, performance statistics, and quality assessments. RESULTS: Fourteen studies met the inclusion criteria, covering 26 risk models. Sensitivity and specificity were used in 9 risk screening tools, with Hazard Ratios and C-Statistics assessing diabetes progression in six. Common risk factors included age, BMI, family history of diabetes, and hypertension. Non-invasive tools and predictive models showed promise, with most studies assessed as having a low risk of bias using QUADAS-2. High-sensitivity tools utilizing FBG, HbA1c, and OGTT cutoffs demonstrated effectiveness but require balancing cost and feasibility for broader implementation. CONCLUSION: A range of different screening tools has been tested that could identify people with prediabetes or a high risk of developing type 2 diabetes. However, where sufficient evidence was available to compare tools across studies the performance of these tools was inconsistent. Several tools have only been investigated in single studies, with uncertainty around their wider generalisability. Clinicians or researchers wishing to screen people for prediabetes or a high risk of developing type 2 diabetes using any of these tools should be aware of their potential limitations. The full text of the article is available in the electronic version of the journal on the website www.dia-endojournals.ruKeywords
This publication has 52 references indexed in Scilit:
- Who self‐cares wins: an updated perspective on men and self‐careTrends in Urology & Men's Health, 2019
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045Diabetes Research and Clinical Practice, 2018
- Dietary Patterns and Whole Plant Foods in Aging and Disease2018
- External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney DiseaseJournal of General Internal Medicine, 2017
- Risk assessment tools for detecting those with pre-diabetes: A systematic reviewDiabetes Research and Clinical Practice, 2014
- Evaluation of non-invasive screening measures to identify individuals with prediabetesDiabetes Research and Clinical Practice, 2014
- How diabetes risk assessment tools are implemented in practice: A systematic reviewDiabetes Research and Clinical Practice, 2014
- Quality assessment of comparative diagnostic accuracy studies: our experience using a modified version of the QUADAS‐2 toolResearch Synthesis Methods, 2013
- A Novel Risk Classification Paradigm for Patients With Impaired Glucose Tolerance and High Cardiovascular RiskThe American Journal of Cardiology, 2013
- Lack of Exercise Is a Major Cause of Chronic DiseasesComprehensive Physiology, 2012